Patient yellow card scheme launched nationwide

Yellow card scheme opens to patients |
Patients who suspect they have experienced side effects can now make reports about prescription, over-the-counter, herbal and complementary medicines direct to the Medicines and Healthcare products Regulatory Agency, following the launch of a nationwide pilot of patient yellow card reporting forms this week.
The nationwide launch follows a successful trial run in parts of the
UK earlier this year. Reporting forms will be sent to pharmacies, GP
surgeries and other NHS health care sites next week, and reports can
also be made at www.yellowcard.gov.uk or by telephone on 0808 100 3352.
The Royal Pharmaceutical Society welcomed the scheme, but warned that
reports made by patients should not replace pharmacists’ reports.
The Association of the British Pharmaceutical Industry said that patient
reports will provide a valuable source of information for the MHRA and
for manufacturers. But it added that patients may have difficulty distinguishing
unexpected side effects from disease symptoms and other unrelated health
problems and so careful analysis of the reports will be critical.
Alison Blenkinsopp, a member of the Committee on the Safety of Medicines
working group on patient reporting, stressed the importance of community
pharmacies as a distribution point for patient reporting forms. There
are also links to the new community pharmacy contract, she added. “The
Department of Health is encouraging primary care trusts to include patient
reporting as one of their public health campaigns,” she said. “And
it is also part of signposting, in telling patients that the MHRA is
where reports should be directed.”
The patient scheme will also provide different information from that
in other reports, Caroline Kelham, project manager at the Medicines Partnership,
said. “Side effects that might seem trivial to a health professional
may have an enormous effect on a patient’s ability to carry out
normal daily tasks,” she said. |